Effects of Insulin Aspart 30 versus Glimepiride on B Islet Cell Function in Patients with Newly Diagnosed Type 2 Diabetes / 中国药房

ABSTRACT

OBJECTIVE:To discuss the effects of different intensive treatment on B islet cell function in patients with newly diagnosed type 2 diabetes. METHODS: 54 patients who had been newly diagnosed as having type 2 diabetes were randomly assigned to receive Insulin aspart 30 or Glimepiride combined with Metformin (oral hypoglycemic agent). The blood glucose, glycosylated hemoglobin (HbA1c), and B islet cell function in two groups before and after treatment were followed. RESULTS: After treatment, blood glucose and glycosylated hemoglobin (HbA1c) in both group lowered significantly (P